Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion type Assertion NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_head.
- NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion description "[These findings suggest that 1) SCLC has an IGFBP-2 overexpression mechanism distinct from NSCLC, 2) secreted IGFBP-2 contributes to the slow growth of SCLC in vitro, and 3) the epigenetic alterations in the IGFBP-2 promoter contribute to the striking differences in IGFBP-2 expression between SCLC and NSCLC in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_provenance.
- NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion evidence source_evidence_literature NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_provenance.
- NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion SIO_000772 19679880 NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_provenance.
- NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion wasDerivedFrom befree-20140225 NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_provenance.
- NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_assertion wasGeneratedBy ECO_0000203 NP511906.RASSP3-LniAF143B07H19WEfnGCa2zKCziiswhAnEZEmg130_provenance.